HistoSonics, Inc. recently announced the completion of patient enrollment in the #HOPE4KIDNEY pivotal trial of its Edison histotri ...

Medtronic announced the treatment of the first patient in the United States in the Global SYMPLICITY Registry (GSR) DEFINE. The cl ...

Penumbra, Inc. announced that data from the THRIVE study demonstrated the potential of the company’s computer assisted vacuum ...

Penumbra, Inc. announced the FDA clearance and launch of the Ruby XL system, part of the company’s Ruby portfolio of peripher ...

Teleflex Manta Vascular Closure Device Bioresorbable implant Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035 Indicated for closure of femoral artery access sites while reducing time ...

We value keeping the Device Guide up to date.

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

TriSalus Life Sciences, Inc. announced the launch of its TriNav FLX infusion system, the latest addition to the company’s Tri ...

Managing peripheral arterial occlusions, particularly acute limb ischemia, remains a critical priority in vascular care. Rapid restoration of perfusion is essential to preserving limb viability, yet ...